Table 1.
Studies evaluating the efficacy and safety of Metformin in male patients affected by acne (GAGS: Global Acne Grading System, HOMA-IR: homeostasis model assessment-insulin resistance).
Study | Population | Mean Age—Year | Metformin | GAGS | HOMA-IR | BMI kg/m2 | Plasma Insulin, μIU/mL | Total Cholesterol mg/dL | HDL Cholesterol mg/dL | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Control | Case | Control | p Value | Case | Control | Case | Control | Case | Control | p Value | Case | Control | p Value | Case | Control | p Value | Case | Control | Case | Control | |
Robinson et al., 2019 [37] | 42 (35.7% male) | 42 (23.8% male) | 22.6 | 23.2 | 0.501 | Yes | N/A | N/A | 1.6 | 1.8 | 0.295 | 21.6 | 22.6 | 0.303 | 7.4 | 8.2 | 0.468 | N/A | N/A | N/A | N/A | |
Fabbroccini et al. 2016 [46] | 10 | 10 | 19.5 | 19.5 | N/A | Yes | 14 ± 10.4 | 19.4 ± 7.418 | 1.5 ± 0.1 | 1.5 ± 0.8 | N/A | 22.9 ± 3.5 | 24.1 ± 2.5 | N/A | 9.6 ± 7.5 | 10.4 ± 1.6 | N/A | 165 ± 4.8 | 166 ± 14.5 | 49.5 ± 0.5 | 50 ± 0.4 |